A new trading day began on Tuesday, with Voyager Therapeutics Inc (NASDAQ: VYGR) stock price down -7.29% from the previous day of trading, before settling in for the closing price of $3.84. VYGR’s price has ranged from $2.64 to $8.27 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 1.48% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -87.10%. With a float of $45.29 million, this company’s outstanding shares have now reached $55.43 million.
In an organization with 172 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 100.0%, operating margin of -289.8%, and the pretax margin is -251.89%.
Voyager Therapeutics Inc (VYGR) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Voyager Therapeutics Inc is 18.34%, while institutional ownership is 59.94%. The most recent insider transaction that took place on Aug 18 ’25, was worth 70,680. Before that another transaction happened on Apr 02 ’25, when Company’s Chief Medical Officer sold 10,086 for $3.43, making the entire transaction worth $34,595. This insider now owns 157,914 shares in total.
Voyager Therapeutics Inc (VYGR) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.16 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.48 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -87.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.86% during the next five years compared to 1.48% growth over the previous five years of trading.
Voyager Therapeutics Inc (NASDAQ: VYGR) Trading Performance Indicators
Here are Voyager Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.85, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.49 in one year’s time.
Technical Analysis of Voyager Therapeutics Inc (VYGR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.74 million. That was better than the volume of 0.53 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 79.42%.
During the past 100 days, Voyager Therapeutics Inc’s (VYGR) raw stochastic average was set at 72.91%, which indicates a significant increase from 66.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.30 in the past 14 days, which was higher than the 0.23 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.27, while its 200-day Moving Average is $4.32. However, in the short run, Voyager Therapeutics Inc’s stock first resistance to watch stands at $3.78. Second resistance stands at $4.00. The third major resistance level sits at $4.12. If the price goes on to break the first support level at $3.44, it is likely to go to the next support level at $3.32. The third support level lies at $3.10 if the price breaches the second support level.
Voyager Therapeutics Inc (NASDAQ: VYGR) Key Stats
With a market capitalization of 197.47 million, the company has a total of 55,469K Shares Outstanding. Currently, annual sales are 80,000 K while annual income is -65,000 K. The company’s previous quarter sales were 5,200 K while its latest quarter income was -33,380 K.
